PeptiVir, Inc.

PeptiVir owns a platform technology for the creation of new vaccines against influenza (universal), RSV, parainfluenza, SARS, HIV and Ebola viruses.

  • Stage Not Set
  • Industry Biotechnology
  • Location Aurora, CO, USA
  • Currency USD
  • Employees 0
  • Website peptivir.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free